American Funds Conservative Growth and Income Portfolio Class ABLE-F-2 (CIQGX) – cena podielového fondu a novinky

DomovCIQGX • podielový fond

American Funds Conservative Growth and Income Portfolio Class ABLE-F-2

14,71 $

13. 2. · USD · MUTF · Vylúčenie

American Funds Conservative Growth and Income Portfolio Class F-3

14,67 $

INPDX0,14 %

American Funds Conservative Growth and Income Portfolio Class R-2

14,56 $

RINBX0,21 %

American Funds Conservative Growth and Income Portfolio Class 529-A

14,66 $

CIPAX0,21 %

American Funds Conservative Growth and Income Portfolio Class 529-C

14,60 $

CIPCX0,21 %

American Funds Conservative Growth and Income Portfolio Class F-2

14,70 $

INPEX0,20 %

American Funds Conservative Growth and Income Portfolio Class A

14,67 $

INPAX0,20 %

American Funds Conservative Growth and Income Portfolio Class R-3

14,62 $

RNCCX0,14 %

American Funds Conservative Growth and Income Portfolio Class C

14,57 $

INPCX0,21 %

American Funds Conservative Growth and Income Portfolio Class R-2E

14,66 $

RNBEX0,21 %

American Funds Conservative Growth and Income Portfolio Class R-1

14,57 $

RNCAX0,21 %

Podielový fond

Predch. zatv. cena

14,68 $

Návratnosť od začiatku tohto roka

2,04 %

Pomer nákladov

0,33 %

Kategória

Moderate Allocation

Morningstar Rating

Čisté aktíva

614,19 tis. USD

Výnos

3,78 %

Vstupný poplatok

Dátum založenia

30. 10. 2020

Novinky na trhu

Yahoo Finance

pred 15 hodinami

Stock market today: S&P 500, Dow, Nasdaq gains fizzle as CPI inflation cools, weekly losses loom

Investor's Business Daily

pred 13 hodinami

Stock Market Today: Dow Ends Choppy Session Higher, Nasdaq Slips; Travel Name Falls Again (Live Coverage)

AOL.com

pred 3 hodinami

The Stock Market and Bond Market Flash Warnings Not Seen in Decades. History Says the S&P 500 Will Do This Next.

.INX

0,050 %

The Wall Street Journal

pred 11 hodinami

Winners and Losers in a Tough Week for Stocks

The 5 Best Artificial Intelligence (AI) Stocks to Buy for February

Moderna (MRNA) Quarterly Loss Narrows To US$200 Million Challenging Bearish Profitability Narratives

MRNA

5,29 %